The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAshmore Regulatory News (ASHM)

Share Price Information for Ashmore (ASHM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 199.30
Bid: 199.40
Ask: 199.80
Change: 0.10 (0.05%)
Spread: 0.40 (0.201%)
Open: 198.00
High: 199.60
Low: 198.00
Prev. Close: 199.20
ASHM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

15 Jan 2024 07:00

RNS Number : 6032Z
Ashmore Group PLC
15 January 2024
 

Ashmore Group plc15 January 2024

SECOND QUARTER ASSETS UNDER MANAGEMENT STATEMENT

Ashmore Group plc ("Ashmore", "the Group"), the specialist Emerging Markets asset manager, announces the following update to its assets under management ("AuM") in respect of the quarter ended 31 December 2023.

Assets under management

Theme

Actual30 September 2023

(US$ billion)

Estimated31 December 2023

(US$ billion)

Movementpre reclassification1

 (%)

- External debt

8.9

9.5

+7%

- Local currency

18.4

18.8

+2%

- Corporate debt1

5.5

5.2

+2%

- Blended debt1

11.3

12.4

+6%

Fixed income

44.1

45.9

+4%

Equities

6.0

6.5

+8%

Alternatives

1.6

1.6

-

Total

51.7

54.0

+4%

 

Assets under management increased by US$2.3 billion over the period, comprising positive investment performance of US$3.9 billion and net outflows of US$1.6 billion.

The Group's net outflows reduced from prior quarters as, while there continues to be some risk aversion among certain investors, clients responded to the improving global macro environment. Equities delivered a net inflow and, within the fixed income themes, the outflows were broadly spread with no significant patterns.

The Fed's signalling of the end of its rate hiking cycle and continued economic stability in many emerging countries delivered strong performance across Emerging Markets over the three months. Fixed income indices rose by 6% to 9% and equities increased by 8%, and the majority of Ashmore's strategies outperformed over the quarter. Ashmore's longer-term relative performance (over one, three and five years) remains consistent.

Mark Coombs, Chief Executive Officer, Ashmore Group plc, commented:

"Emerging Markets delivered good returns and outperformed most developed world indices in 2023 due to superior economic growth, effective monetary policies and the benefits of a weaker US dollar as the Fed reaches the end of its tightening cycle. These factors, along with attractive absolute and relative valuations, will support Emerging Markets asset prices in 2024, leading to outperformance and higher allocations from investors who currently have significantly underweight allocations to Emerging Markets. Ashmore continues to deliver outperformance for clients across a broad range of strategies, and activity levels have begun to reflect the improving outlook for the global macro environment."

 

 

Notes

 

1. During the quarter, assets totalling US$0.4 billion were reclassified from corporate debt to blended debt as a result of changes to benchmarks. The quarter-on-quarter % movements and the commentary on flows exclude the effects of this reclassification. Including the reclassification, corporate debt AuM decreased by 5% and blended debt AuM increased by 10% over the period.

Local currency AuM includes US$6.3 billion of AuM managed in overlay/liquidity strategies (30 September 2023: US$6.6 billion).

For the translation of US dollar-denominated balance sheet items, the GBP:USD exchange rate was 1.2748 at 31 December 2023 (30 June 2023: 1.2714; 31 December 2022: 1.2029). For the translation of US dollar management fees, the average GBP:USD exchange rate achieved for the first half of the financial year was 1.2572 (H1 2022: 1.1795).

Ashmore will announce its interim results in respect of the six months ending 31 December 2023 on 7 February 2024.

 

For further information please contact:

Ashmore Group plcPaul MeasdayInvestor Relations +44 (0)20 3077 6278 ir@ashmoregroup.com

FTI ConsultingNeil Doyle +44 (0)7771 978 220Kit Dunford +44 (0)7717 417 038 ashmore@fticonsulting.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFFDLAIFLIS
Date   Source Headline
17th Apr 20187:00 amRNSTrading Statement
4th Apr 20184:32 pmRNSDirector/PDMR Shareholding
29th Mar 20184:00 pmRNSDirector/PDMR Shareholding
8th Feb 20187:00 amRNSHalf-year Report
16th Jan 20187:00 amRNSTrading Statement
6th Dec 20171:55 pmRNSDirectorate Change
5th Dec 201711:45 amRNSDirector/PDMR Shareholding
5th Dec 201710:57 amRNSDirector/PDMR Shareholding
20th Oct 20173:08 pmRNSResult of AGM
13th Oct 20174:49 pmRNSDirector/PDMR Shareholding
13th Oct 20177:00 amRNSTrading Statement
19th Sep 20172:11 pmRNSDirector/PDMR Shareholding
19th Sep 20172:07 pmRNSDirector/PDMR Shareholding
7th Sep 20177:00 amRNSFinal Results
14th Jul 20177:00 amRNSTrading Statement
16th Jun 20177:00 amRNSInvestor presentation
21st Apr 20174:30 pmRNSDirector/PDMR Shareholding
18th Apr 20177:00 amRNSTrading Statement
10th Apr 20175:19 pmRNSDirector/PDMR Shareholding
29th Mar 20179:23 amRNSHolding(s) in Company
28th Mar 20174:54 pmRNSDirector/PDMR Shareholding
9th Feb 20177:00 amRNSHalf-year Report
16th Jan 20177:00 amRNSTrading Statement
21st Oct 20163:57 pmRNSResult of AGM
14th Oct 20167:00 amRNSTrading Statement
21st Sep 20164:30 pmRNSDirector/PDMR Shareholding
21st Sep 20164:30 pmRNSDirector/PDMR Shareholding
6th Sep 20167:00 amRNSFinal Results
10th Aug 201610:45 amRNSHolding(s) in Company
14th Jul 20167:00 amRNSTrading Statement
18th May 201610:00 amRNSAppointment of joint corporate broker
20th Apr 20164:28 pmRNSHolding(s) in Company
19th Apr 20167:00 amRNSTrading Statement
15th Apr 20164:39 pmRNSHolding(s) in Company
4th Apr 20168:56 amRNSDirector/PDMR Shareholding
24th Mar 20165:30 pmRNSDirector/PDMR Shareholding
23rd Mar 20168:21 amRNSHolding(s) in Company
11th Feb 20167:00 amRNSHalf Yearly Report
14th Jan 20167:00 amRNSTrading Statement
11th Dec 20155:30 pmRNSDirector/PDMR Shareholding
11th Dec 20155:28 pmRNSDirectorate Change
7th Dec 201510:13 amRNSDirector/PDMR Shareholding
13th Nov 20159:15 amRNSDirector/PDMR Shareholding
28th Oct 201511:56 amRNSForm 8.3 - Al Noor Hospitals Group PLC
28th Oct 201511:52 amRNSForm 8.3 - NMC Health plc
27th Oct 20154:42 pmRNSHolding(s) in Company
22nd Oct 20153:01 pmRNSDirectorate Change
22nd Oct 20152:57 pmRNSResult of AGM
15th Oct 20157:00 amRNSTrading Statement
22nd Sep 20154:30 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.